Simultaneous HPLC of Metformin, Glipizide and Gliclazide, and Metformin Uptake and Protection of HEI-OC1 from Hyperglycaemia
The antidiabetic drugs metformin, glipizide and gliclazide have been used for many years to control blood glucose levels. In recent years, they have gained importance in non-diabetic pharmacological purposes including cancer and hearing loss treatment. Co-administration of these therapeutics represe...
Saved in:
| Main Authors: | Ahmed Gedawy, Hani Al-Salami, Crispin R. Dass |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Applied Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3417/14/22/10469 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
What’s the latest on sulphonylureas in the management of type 2 diabetes?
by: Gail Mkele
Published: (2013-12-01) -
Where do sulphonylureas fit in the type 2 diabetes guidelines?
by: Gail Mkele
Published: (2014-07-01) -
Stress granules formation in HEI-OC1 auditory cells and in H4 human neuroglioma cells secondary to cisplatin exposure
by: Hebatallah Abdelrasol, et al.
Published: (2024-10-01) -
Perioperative hyperglycaemia
by: B.M. Gardner
Published: (2012-06-01) -
Russian Association of Endocrinologists reports commencement of Glimecomb clinical use
by: Editorial team Diabetes Mellitus
Published: (2011-12-01)